SCHEMBL23959780

SCHEMBL23959780

S=C(Nc1cccc2cccnc12)c1ccccc1Cl

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.71
MEN1 O00255 9/20 0.63
KMT2A Q03164 9/20 0.63
CASP3 P42574 1/20 0.63
SENP8 Q96LD8 1/20 0.63
SENP7 Q9BQF6 1/20 0.63
CYP1A2 P05177 1/20 0.62
CYP3A4 P08684 1/20 0.62
MAPT P10636 4/20 0.56
L3MBTL1 Q9Y468 3/20 0.56
ALDH1A1 P00352 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.54
KDM4E B2RXH2 1/20 0.54
PLEC Q15149 1/20 0.53
TDP1 Q9NUW8 2/20 0.51
GAA P10253 1/20 0.51
RAB9A P51151 2/20 0.51
NPC1 O15118 1/20 0.51
SLC40A1 Q9NP59 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959781 0.83 KDR (0.71) KDRMEN1KMT2ACASP3SENP8
SCHEMBL27947220 0.83 KDR (1.00) KDRMEN1KMT2ACASP3SENP8
SCHEMBL29510019 0.83 KDR (1.00) KDRMEN1KMT2ACASP3SENP8
SCHEMBL4512999 0.77 CYP1A2 (1.00) KDRMEN1KMT2ACASP3SENP8
SCHEMBL27803940 0.76 KDR (0.81) KDRMEN1KMT2ACASP3SENP8
SCHEMBL6537780 0.74 KDR (0.75) KDRMEN1KMT2ACASP3SENP8
SCHEMBL23959777 0.74 CYP1A2 (0.71) KDRMEN1KMT2ACASP3SENP8
SCHEMBL3549883 0.74 CYP1A2 (0.71) KDRMEN1KMT2ACASP3SENP8
SCHEMBL4512996 0.74 CYP1A2 (0.71) KDRMEN1KMT2ACASP3SENP8
SCHEMBL3777648 0.74 KDR (0.78) KDRMEN1KMT2ACASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210332038-A1 6H-IMIDAZO[4,5,1-ij]QUINOLONE, SYNTHESIS METHOD AND USE THEREOF HANGZHOU NORMAL UNIVERSITY 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332038-A1 6H-IMIDAZO[4,5,1-ij]QUINOLONE, SYNTHESIS METHOD AND USE THEREOF ABL1, KCNK4, KCNJ4 KDR 652/4885MEN1 3196/4885KMT2A 866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.